Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Elevar Therapeutics

Clinical trials sponsored by Elevar Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New pill targets rare cancer gene in 30-Patient trial Results expected Sep 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Completed 1 Terminated 1
Sort by
  • New pill targets rare cancer gene in 30-Patient trial

    Disease control Recruiting now

    This phase 2 trial tests an oral drug called lirafugratinib in 30 adults with advanced solid tumors (excluding bile duct cancer) that have an FGFR2 gene fusion or rearrangement. Participants take the drug regularly and visit the clinic for checkups. The main goal is to see if the…

    Phase 2 • Sponsor: Elevar Therapeutics • Aim: Disease control

    Last updated Sep 05, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space